ArticleJournal of hematology & oncology2020

In vivo evaluation of CD38 and CD138 as targets for nanoparticle-based drug delivery in multiple myeloma.

David T Omstead et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.